Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients

British Journal of Cancer

Volumn 74, Issue 9, 1996, Pages 1445-1451

  Barnes, D M ^a   Harris, W H ^a   Smith, P ^a   Millis, R R ^a   Rubens, R D ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Human breast cancer; Immunohistochemistry; Oestrogen progesterone receptor; Tamoxifen responsiveness

Indexed keywords

ANTIBODY; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOSOL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIGAND BINDING; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; STAINING;

EID: 0029804330     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.563     Document Type: Article

References (24)

1. AL SAATI T, CLAMENS S, COHEN-KNAFO E, FAYE JC, PRATS H, COINDRE JM, WAFFLART J, CAVERIVIERE, BAYARD F AND DELSOL G. (1993). Production of monoclonal antibodies to human oestrogen receptor protein (ER) using recombinant ER (RER). Int. J. Cancer, 55, 651 - 654.
2. ANDERSEN J, THORPE SM, KING WJ, ROSE C, CHRISTENSEN I, RASMUSSEN BB AND POULSEN HS. (1990). The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays. Eur. J. Cancer, 26, 442 - 449.
3. BARNES DM AND MILLIS RR. (1995). Oestrogen receptors: the history, the relevance and the methods of evaluation. In Progress in Pathology Vol 2. Kirkham N. Lemoine N (eds). Churchill Livingtsone: London.
4. BOBROW LG, HAPPERFIELD LC, GREGORY WM, SPRINGALL RD AND MILLIS RR. (1994). The classification of ductal carcinoma in situ and its association with biological markers. Semin. Diagn. Pathol., 11, 199 - 207.
5. ELSTON CW. (1984). The assessment of histological differentiation in breast cancer. Aust. NZ. J. Surg., 54, 11 15.
6. GREENE GL, NOLAN C, ENGLER JP AND JENSEN EV. (1980). Monoclonal antibodies to human estrogen receptor. Proc. Natl Acad. Sci. USA, 77, 5115 - 5119.
7. GOULDING H, PINDER S, CANNON P, PEARSON D, NICHOLSON R, SNEAD D, BELL J, ELSTON CWE, ROBERTSON JF, BLAMEY RW AND ELLIS IO. (1995). A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum. Pathol., 26, 291 - 294.
8. HAYWARD JL, CARBONE PP, HEUSON JC, KUMAOKA S, SEGAL-OFF A AND RUBENS RD. (1977). Assessment of response to therapy in advanced breast cancer. Cancer, 39, 1289 - 1294.
9. HAYWARD JL, MEAKIN JW AND STEWARD HJ. (1978). Assessment of response and breast cancer. Semin. Oncol., 5, 445 - 449.
10. HORWITZ KB, MCGUIRE WL, PEARSON OH AND SEGALOFF A. (1975). Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science, 189, 726 - 727.
11. JENSEN EV AND DESOMBRE ER. (1993). Steroid hormone binding and hormone receptors In Cancer Medicine. 3rd edn. Holland JF, Frie E III, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR (eds). pp. 815 - 823. Lea and Febinger: Philadelphia.
12. KAPLAN EL AND MEIER P. (1958). Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457 - 481.
13. KING RJB, REDGRAVES, HAYWARD JL, MILLIS RR AND RUBENS RD. (1979). The measurement of receptors for oestradiol and progesterone in human breast tumors. In Steroid Receptor Asssays in Breast Tumors: Methodological and Clinical Aspects. King RJB (ed) pp. 55 - 73. Alpha-Omega: Cardiff.
14. KING WL, DESOMBRE ER, JENSEN EV AND GREENE GL. (1985). Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res., 45, 293 - 304.
15. KINSEL LB, SZABO E, GREENE GL, KONRATH J, LEIGHT GS AND MCCARTY KS JR. (1989). Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Rex., 49, 1052 - 1056.
16. KORENMAN SG AND DUKES BA. (1970). Oestrogen receptors in human breast cancer: the Edinburgh experience. J. Clin. Endocrinol., 30, 659 - 664.
17. PRESS MF AND GREENE GL. (1988). Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Endocrinology, 122, 1165 - 1175.
18. REINER A, NEUMEISTER B, SPONA J, REINER G, SCHEMPER M AND JAKESZ R. (1990). Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res., 50, 7057 - 7061.
19. REMMELE W AND STEGNER HE. (1987). Immunhistochemischer nachweis von ostrogenerezeptoren (ER-ICA) im mammakarizinomgewebe: vorschlag zur einheitlichen bewertung des untersuchungsbefundes. Frauenarzt, 28, 41 - 43.
20. SACCANI JOTTI G, JOHNSTON SRD, SALTER J, DETRE S AND DOWSETT M. (1994). Comparison of new immunohistochemical assays for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. J. Clin. Pathol., 47, 900 905.
21. STEWART J, ROGER K, HAYWARD J AND RUBENS R (1982). Estrogen and progesterone receptors: correlation of response rates, site and timing of receptor analysing. Br. Cancer Res. Treat., 2, 243 - 250.
22. TAYLOR CR, SHI S, CHAIWUN B, YOUNG L, ASHRAF IMAM S AND COTE RJ. (1994). Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum. Pathol., 25, 263 - 270.
23. UNDERWOOD JCE. (1983). Oestrogen receptors in human breast cancer: review of histopathological correlates and critique of histochemical methods. Diagn. Histopathol., 6, 1 - 22.
24. VERONESE SM, BARBARESCHI M, MORELLI L, ALDOVINI D, MAURI FA, CAFEO O, GAMBACORTA M AND PALMA PD. (1995). Predictive value of ER1D5 antibody immunostaining in breast cancer. a paraffin-based retrospective study of 257 cases. Appl. Immunohistochem., 3, 85 - 90.